Abstract:
Introduction
Copper(II) complexes with non-steroidal anti-inflammatory drugs (NSAIDs) as ligands have attracted a lot of attention recently, as stressed in the review papers [1] [2] [3] . The exemplary NSAIDs whose copper complexes have been studied are aspirin and other derivatives of salicylic acid [4] [5] [6] , niflumic acid [7] , tolfenamic acid [8] , oxicams [9, 10] , ketoprofen derivatives [11] , diclofenac [12, 13] , naproxen [13] [14] [15] [16] [17] , ibuprofen [18] [19] [20] [21] [22] . Besides aspirin, ibuprofen seems to be the most commonly applied NSAID (paracetamol is the most common drug but it rather cannot be classified as anti-inflammatory agent) [23] . Naproxen and ketoprofen have structures similar to that of ibuprofen, these three drugs are aromatic derivatives of propanoic acid substituted at the 2 position, namely ibuprofen -(RS)-2-(4-(2-methylpropyl)phenyl)propanoic acid, naproxen -(+)-(S)-2-(6-methoxynaphthalen-2-yl) propanoic acid and ketoprofen -(RS)-2-(3-benzoylphenyl) propanoic acid (Scheme 1).
It is well known that electrospray ionization mass spectrometry (ESI-MS) is a very good tool allowing detection of metal-organic ligand complexes present in solution. Furthermore, ESI-MS allows detection of the species present in solution which are difficult to observe by other methods [24] . The knowledge of the ions which exist in solution is important from the practical point of view since they can be expected to exist under physiological conditions.
On the other hand, a number of processes may occur in the gas phase leading to the formation of ions not earlier present in solution. The most common processes occurring under ESI conditions are counter ion attachment, deprotonation of coordinated solvent molecules, reduction of metals, that are easily reduced under ESI conditions (e.g. Cu 2+ ). Sometimes, under ESI conditions more complicated processes may occur, namely copper reduction may be accompanied by formation of cluster ions [25] or formation of a helical complex [26] . Occurrence of these processes may be
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The solutions containing one of the copper salts (CuCl 2 , Cu(ClO 4 ) 2 , Cu(NO 3 ) 2 , and CuSO 4 ) and one of the non-steroidal anti-inflammatory drugs (NSAIDs, ibuprofen, ketoprofen or naproxen) were analyzed by electrospray ionization mass spectrometry. ) were observed at low cone voltage, thus these complexes must have already existed in the solution analysed. Therefore, such complexes may also exist under physiological conditions. desirable, since they allow studies of the interactions between specific chemical individuals in the gas phase in the absence of a solvent. The importance of gas-phase studies is described in detail in the excellent paper by Dearden et al. [27] .
The aim of this study is to identify the copper complexes with NSAIDs (namely ibuprofen, ketoprofen and naproxen) by using ESI-MS, thus in the solution as well in the gas phase. We have focused on the complexes which have not been earlier observed by other methods.
Experimental procedure
The NSAIDs used ((RS)-ibuprofen, (RS)-ketoprofen and (S)-naproxen), have been obtained from SigmaAldrich (Poznań, Poland). All three drugs are chiral compounds, however, for the presented study (the discussed binuclear copper complexes contains only one drug molecule) the chirality is of no importance.
The ESI mass spectra were obtained on a Waters/Micromass (Manchester, UK) ZQ2000 mass spectrometer (single quadrupole type instrument, Z-spray, software MassLynx V3.5). The sample solutions were prepared in methanol (or methanol/water mixture), at the concentration of drug and copper salt (CuCl 2 , Cu(ClO 4 ) 2 , Cu(NO 3 ) 2 , and CuSO 4 ) of 10 -4 mol dm -3 . The sample solutions were infused into the ESI source using a Harvard pump at a flow rate of 80 µL min -1 . The ESI source potentials were capillary 3 kV, lens 0.5 kV, extractor 4 V and cone voltage (CV) 10-60 V. This latter parameter had the most profound effect on the mass spectra obtained. Increase in this voltage leads to the so-called "in-source" fragmentation/dissociation, but a too low cone voltage may cause a drop in sensitivity. The pressure in this region is about 1.5 Pa, which is low enough to allow an ion a significant mean free path of travel before collision occurs, yet high enough for the probability of collision to be still significant [28] . It is possible that collisions may induce formation of some ions [29] . The source temperature was 120 o C and the desolvation temperature was 300 o C. Nitrogen was used as the nebulising and desolvating gas at flow-rates of 100 and 300 L h -1 , respectively.
Results and discussion
Among the copper salts used, three of them, namely CuCl 2 , Cu(ClO 4 ) 2 and Cu(NO 3 ) 2 , yielded the unexpected binuclear complexes with NSAIDs. The complexes are unexpected because they have drug:metal stoichiometry 1:2, the complexes of such stoichiometry have not been earlier observed. The complexes of copper(II) perchlorate were analogical to those observed for copper(II) nitrate, as shown further. The attachment of a bivalent counter ion SO 4 2-could lead to the formation of a neutral complex whose detection by ESI-MS is impossible.
In the ESI mass spectra obtained there was a number of intense peaks assigned to ions which are not subjects of this work. For example in the mass spectrum shown in Fig. 1a + at m/z 256. Only the ions containing a drug molecule and two copper atoms (as it always clearly results from a characteristic isotopic pattern) will be discussed here.
Binuclear copper complexes derived from
CuCl 2 Fig. 1 shows the ESI mass spectrum of methanol solution containing ibuprofen and CuCl 2 obtained at cone voltage 40 V (CV=40V, for clarity the spectrum in Fig. 1a is shown in the m/z range 200-500 Binuclear copper complexes with non-steroidal anti-inflammatory drugs as studied by electrospray ionization mass spectrometry when a mixture of methanol/water (1/1) was used as a solvent instead of pure methanol (as it is expected for the ions formed in the gas phase).
Binuclear copper complexes derived from Cu(ClO 4 ) 2 and Cu(NO 3 ) 2
When copper(II) perchlorate was used instead of copper(II) chloride the binuclear copper complexes were also observed but they were not analogical to that detected for copper chloride. + were most abundant at a low cone voltage 10-20 V, thus they are unstable in gas (at cone voltage 40 V and higher they were not detected). It may be assumed that the ions exist already in solution. If the assumption is true, the solvent composition should strongly affect their formation. As shown in Fig. 5 ) were different from those observed for copper(II) chloride. The observed ions ware found to be unstable in the gas phase. It is reasonable to assume that the ions exist already in solution, which may be of importance from the practical/pharmaceutical point of view. Obviously, the parameters of the solution used for ESI experiments are different from physiological conditions, however, the presence of such ions in physiological solutions cannot be excluded. 
